checkAd

     129  0 Kommentare Resolutions of Annual Geneal Meeting

    April 30, 2024
    Announcement no. 10

    Resolutions of Annual Geneal Meeting

    COPENHAGEN, DENMARK and BOSTON, MA, USA, April 30, 2024, (GLOBE NEWSWIRE) -- BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today held its Annual General Meeting with the following results:

    ITEM 1 - The Board's report on the Company’s activities during the past year was noted by the Annual General Meeting.

    ITEM 2 – The annual report was approved by the Annual General Meeting and the result for the financial year 2023 was approved to be carried forward to the next financial year.

    ITEM 3 - Discharge of liability was granted to the Board of Directors and Executive Management.

    ITEM 4 – The Company’s Remuneration Report for the financial year 2023 was approved by an advisory vote.

    ITEM 5 – The Annual General Meeting approved the following remuneration for the members of the Board of Directors for the financial year 2024 (all unchanged compared to 2023):

    • Cash remuneration
      • Members of the Board of Directors – DKK 250,000
      • Vice Chair of the Board of Directors – DKK 350,000
      • Chair of the Board of Directors – DKK 500,000
    • Board members shall furthermore be entitled to remuneration for participation in committees of DKK 25,000 per committee with an overall maximum remuneration for participation in committees of DKK 50,000 per board member. The Chair and Vice Chair are not entitled to receive additional remuneration for participation in committees.
    • In respect of members of the Board of Directors that are not Danish tax residents, additional contributions will be paid to achieve tax equalization, whereby the relevant members of the Board of Directors are placed as if they were taxed only in the jurisdiction where they are tax resident.
    • In case board members also hold officer or directorships in subsidiaries of the Company, the above-mentioned fees and contributions constitute the aggregate maximum amounts payable for all officer or directorships held in the group. 

    ITEM 6 – The Annual General Meeting re-elected the following board members: John Patrick McDonough, Ninfa Saunders, Michael S. Singer and Don M. Hardison. In addition, the Annual General Meeting elected Henrik Juuel and Mats Thorén as new members of the Board of Directors.

    Seite 1 von 3



    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    Resolutions of Annual Geneal Meeting April 30, 2024Announcement no. 10 Resolutions of Annual Geneal Meeting COPENHAGEN, DENMARK and BOSTON, MA, USA, April 30, 2024, (GLOBE NEWSWIRE) - BioPorto A/S (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on …